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Abstract 1 
Dysfunction of the corneal endothelium (CE) resulting from progressive cell loss leads to corneal 2 
oedema and significant visual impairment. Current treatments rely upon donor allogeneic tissue to 3 
replace the damaged CE. A donor cornea shortage necessitates the development of biomaterials, 4 
enabling in vitro expansion of corneal endothelial cells (CECs). This study investigated the use of a 5 
synthetic peptide hydrogel using poly-ε-lysine (pεK), cross-linked with octanedioic-acid as a potential 6 
substrate for CECs expansion and CE grafts. PεK hydrogel properties were optimised to produce a 7 
substrate which was thin, transparent, porous and robust. A human corneal endothelial cell line 8 
(HCEC-12) attached and grew on pεK hydrogels as confluent monolayers after 7 days, whereas primary 9 
porcine CECs (pCECs) detached from the pεK hydrogel. Pre-adsorption of collagen I, collagen IV and 10 
fibronectin to the pεK hydrogel increased pCEC adhesion at 24 hours and confluent monolayers 11 
formed at 7 days. Minimal cell adhesion was observed with pre-adsorbed laminin, chondroitin 12 
sulphate or commercial FNC coating mix (fibronectin, collagen and albumin). Functionalisation of the 13 
pεK hydrogel with synthetic cell binding peptide H-Gly-Gly-Arg-Gly-Asp-Gly-Gly-OH (RGD) or α2β1 14 
integrin recognition sequence H-Asp-Gly-Glu-Ala-OH (DGEA) resulted in enhanced pCEC adhesion with 15 
the RGD peptide only. pCECs grown in culture at 5 weeks on RGD pεK hydrogels showed zonula 16 
occludins 1 staining for tight junctions and expression of sodium-potassium adenosine triphosphase, 17 
suggesting a functional CE. These results demonstrate the pεK hydrogel can be tailored through 18 
covalent binding of RGD to provide a surface for CEC attachment and growth. Thus, providing a 19 
synthetic substrate with a therapeutic application for the expansion of allogenic CECs and replacement 20 
of damaged CE. 21 
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1. Introduction  1 
The corneal endothelium (CE) is the inner most layer of the cornea and is composed of a single 2 
monolayer of tightly packed, non-replicative endothelial cells on a thickened basement membrane 3 
(Descemet’s membrane (DM)). The primary role of the CE is to maintain the transparency of the 4 
cornea by regulating its hydration through a leaky barrier and active sodium-potassium adenosine 5 
triphosphase (Na+K+ATPase) pumps present on the membrane of corneal endothelial cells (CECs).[1, 6 
2] If CECs are lost, the remaining cells migrate and enlarge to ensure adequate cell coverage to 7 
maintain corneal transparency, however, there is a critical number of CECs required to maintain 8 
adequate pump function (>500 cells/mm2).[3] Acute cell loss due to age, disease (such as Fuchs 9 
endothelial corneal dystrophy (FECD)), degenerative changes (bullous keratopathy) and other causes 10 
including infection, and physical or surgical trauma can eventually result in corneal oedema and 11 
decreased visual acuity.[4]  12 
Currently the only therapeutic treatment for corneal endothelial dysfunction is corneal 13 
transplantation using donor tissue. This treatment involves the replacement of the CE with donor CECs 14 
on their native DM, using most commonly, partial thickness grafts such as Descemet’s stripping 15 
automated endothelial keratoplasty (DSAEK) or Descemet’s membrane endothelial keratoplasty 16 
(DMEK). These procedures are not without complications as there is the risk of graft failure (due to 17 
rejection or gradual cell loss)[5, 6] and graft survival rate is only 70% at 5 years.[7] At present the ratio 18 
of donor tissue to recipient is 1:1 and there is a global shortage of corneas for transplantation, 19 
therefore, alternative therapeutic methods using expanded CECs are being developed as they offer 20 
the advantage of production of several endothelial grafts from one donor to treat multiple 21 
recipients.[5, 8] 22 
CECs possess limited replicative capacity but in vitro expansion is possible, while still maintaining 23 
phenotype and function.[9, 10] Currently, there are two potential modes of delivery of cultured CECs; 24 
direct cell injection into the anterior chamber or transplantation of an engineered graft comprising a 25 
cell monolayer on a carrier/scaffold.[11-14] Preclinical studies have shown conflicting functional 26 
outcomes using injected cells, [11, 15-18] however, a clinical trial of 11 patients with bullous 27 
keratopathy did show injected CECs supplemented with Rho kinase (ROCK) inhibitor Y-27632 28 
increased the density of CECs.[19] A recent publication directly comparing injected CECs with a tissue 29 
engineered graft of CECs in a rabbit model highlighted an important point.[20] When CECs were 30 
injected into the eye of a rabbit with DM removed, the CECs failed to improve corneal transparency 31 
or decrease corneal thickness and were later found to have failed to attach and form a monolayer. In 32 
FECD vision is adversely affected by deposition of focal excrescences, known as guttae, which are 33 
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present in the central DM. The DM must be removed before delivery of an endothelial graft meaning 1 
injected cell therapy will not be suitable for these patients or late stage bullous keratopathy patients 2 
with DM scarring. In these cases there is clearly still a requirement for a tissue engineered graft that 3 
can also fulfil the role of the DM.  4 
Previous studies have demonstrated that CECs can be expanded onto biological substrates, such as 5 
amniotic membrane,[21] decellularised endothelium/stroma and lens capsule.[22-25] CECs grew as 6 
cell monolayers on these substrates and displayed a uniform shape and size, with cell to cell contacts 7 
and expressing typical CEC markers zonula occludens-1 (ZO1), Na+/K+ATPase and connexin 43. 8 
Substrates derived from natural polymers (collagen membranes [23, 24] and sponges [26], 9 
compressed collagen I [27, 28], silk fibroin [29] or synthetic polymers (poly(caprolactone)) or a 10 
combination of both (chitosan and poly(caprolactone) [30, 31]) have been used as materials to mimic 11 
the biological and mechanical properties of DM for culturing CECs. CECs proliferated on these 12 
substrates and maintained their typical morphology and phenotype. Natural polymers used as coating 13 
on culture dishes, such as collagen I [32] and collagen IV, fibronectin, gelatin, laminin and chondroitin 14 
sulphate have also been shown to be beneficial in promoting a cobblestone endothelial-like 15 
morphology.[33-37]  16 
The properties of synthetic substrates can be tightly controlled to produce a customised material with 17 
desired mechanical properties and surface functionalisation to increase e.g. cell adhesion. Synthetic 18 
hydrogels are an attractive option for CE replacement as they would allow the diffusion of water and 19 
biomolecules into the stroma. Our previous studies have shown that poly-ε-lysine (pεK) cross-linked 20 
with octanedioic-acid produces hydrogels that are transparent, are non-toxic to corneal epithelial cells 21 
in vitro and can be cast into contact lens moulds.[38, 39] In addition, following crosslinking of pεK 22 
hydrogels, free amine sites remain for either electrostatic or covalent binding of drugs, proteins or 23 
peptides to the pεK hydrogel. The adaptability of this synthetic material means the pεK hydrogel 24 
properties, such as stiffness and amine functionality, can be tailored to facilitate production of a stable 25 
endothelial monolayer.  26 
 27 
The current study aimed to develop the synthetic pεK hydrogel as a substrate for the expansion of 28 
CECs. The objectives were to manufacture a thin pεK hydrogel film with optimum transparency and 29 
mechanical properties, which maintained sufficient free amines to allow binding of biomolecules (such 30 
as extracellular matrix (ECM) proteins and synthetic cell binding peptides (H-Gly-Gly-Arg-Gly-Asp-Gly-31 
Gly-OH (RGD)  and H-Asp-Gly-Glu-Ala-OH (DGEA)), to enable production of a confluent endothelial cell 32 
monolayer that maintained the characteristic CEC phenotype. We investigated the attachment and 33 
growth of both a human corneal endothelial cell line (HCEC-12) and primary porcine endothelial cells 34 
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(pCEC) onto these pεK hydrogels and the effects of protein and peptide functionalisation of the pεK 1 
hydrogels. The results demonstrate, for the first time, that pεK hydrogels tailored to promote cell 2 
attachment can be used for the expansion of CECs, which displayed a characteristic phenotype in long 3 
term culture.  4 
 5 
2. Materials and Methods 6 
2.1. PεK hydrogel synthesis and material testing  7 
The pεK hydrogel was synthesised from pεK (Bainafo- Zhengzhou Bainafo Bioengineering Co. Ltd) 8 
cross-linked to 60% with octanedioic-acid (Sigma Aldrich, Dorset, UK) to a polymer density of 0.066 9 
g/ml using N-hydroxysulfosuccinimide (NHS, CarboSynth ltd, Berkshire, UK) and 1-ethyl-3-(3-10 
dimethylaminopropyl) carbodiimide (EDCI, CarboSynth ltd, Berkshire, UK). Specifically, pεK (0.692 g) 11 
was dissolved with dH2O (2 ml) in a 15 ml polypropylene universal (Starlab Ltd., Blakelands, UK). 12 
Octanedioic acid (0.210 g) was dissolved in dH2O (1 ml) with N-Methylmorpholine (NMM, Sigma, UK; 13 
0.442 ml). This was placed on a roller until dissolved and added to the pεK solution. An aliquot of 5% 14 
Tween 20 (0.1 ml) was added. NHS (0.232 g) was dissolved in dH2O (1 ml). EDCI (1.157 g) was 15 
separately dissolved in distilled H2O (dH2O) (2 ml). The EDCI and NHS were mixed together and 16 
immediately added to the pεK/octanedioic acid solution before topping up the solution to a final 17 
volume (10 ml) with dH2O. This was inverted ten times. An aliquot of the polymer solution (40 μl) was 18 
pipetted into the condensation rings on the lid of a 48 well plate (Greiner Bio-One GmbH, 19 
Kremsmunster, Austria). These were incubated overnight at room temperature until the pεK hydrogel 20 
had polymerised, followed by 5 x 5 mins dH2O washes.  21 
 22 
Cast pεK hydrogel thickness was measured in the wet state using a modified Draper micromere gauge, 23 
the thickness of a sample of pεK hydrogels used for cell culture (4 for each repeat) were tested and 24 
they had a thickness range of 100 - 130 µm and a diameter of 8 mm. For material testing the pεK 25 
hydrogel solution was cast into a 90 mm petri dish. To analyse the surface hydrophobicity, contact 26 
angle measurements (DSA100, Krüss GmbH, Germany) were performed using a 5 µl drop size, 9 drops 27 
were dispensed randomly across the surface of the pεK hydrogel. The percentage water content of 1 28 
mm diameter pεK hydrogels was measured. Samples were measured in the wet state and then left in 29 
a desiccator overnight to measure dry weight. Mechanical testing was performed until failure using 30 
dog bone punched samples with a width of 2.8 mm and gauge length of 10 mm, using the TST350 31 
tensile tester (Linkam, UK) with a 20 N load cell at 100 µm/s strain rate. The thickness of the pεK 32 
hydrogel sheet was measured prior to punching, thickness values were inputted into the Linkam 33 
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tensile tester to calculate the stress. For transparency testing a 6 mm punch was used. Samples were 1 
placed in a 96 well plate (Griener BioOne) and optical density was recorded across several wavelengths 2 
of the visible spectrum (460 nm, 544 nm, 560 nm, 570 nm and 600 nm) using a FLUOstar 3 
spectrophotometer (BMG Labtech, UK), a Contaflex 75 contact lens was used as a control (Menicon, 4 
UK). All material testing was repeated with 3 synthesised pεK hydrogels to give an n=3. The 5 
microstructure of the pεK hydrogel was investigated using Multimode 8 atomic force microscope 6 
(AFM) with Nanoscope V controller (Bruker, UK). A silicon nitride cantilever of spring constant 0.4 N/m 7 
was used in scanasyst mode. A 2 µm2 region was scanned at a rate of 1 Hz with 512 samples / line. The 8 
scans were subjected to 0th order plane fit, to remove image bow.  9 
 10 
2.2. Functionalisation of pεK hydrogels  11 
The pεK hydrogel was functionalised either by electrostatically binding ECM proteins onto the pεK 12 
hydrogel or via covalently binding peptides to the pεK hydrogel. All pεK hydrogels were washed in 70% 13 
(v/v) ethanol for 1 hour (hr) and then washed extensively in sterile Phosphate Buffered Saline (PBS, 14 
Oxoid, UK).  15 
The following proteins were electrostatically bound to pεK hydrogels (all Sigma unless stated 16 
otherwise): human fibronectin (50 µg/ml), rat tail collagen I (100 µg/ml), collagen IV from human 17 
placenta (100 µg/ml), chondroitin sulphate (20 mg/ml), laminin from human fibroblasts (50 µg/ml) 18 
and the commercial FNC coating mix ® (composed of fibronectin, collagen and albumin) (Enzo 19 
Lifesciences) for 1 hr at 37°C, followed by the removal of excess solution.[40] 20 
Prior to covalent binding, precast pεK hydrogels were washed 3 times with 10 % NMM in dH2O solution 21 
then washed 3 times in dH2O. Cell binding peptide H-Gly-Gly-Arg-Gly-Asp-Gly-Gly-OH (RGD, Spheritech 22 
ltd, UK), and α2β1 integrin recognition sequence H-Asp-Gly-Glu-Ala-OH (DGEA, Sigma, UK) were 23 
covalently bound to precast pεK hydrogels via the available amine sites in a 0.25 M solution of NHS 24 
and EDCI dissolved in dH20. RGD was bound at 100 % loading capacity to available amine groups 25 
whereas DGEA was bound at 5% and 1% loading capacity. Specifically 127 mg of RGD was added to 26 
0.072 g NHS and 0.12 g EDCI in 2.5 ml dH2O and mixed until dissolved. The precast pεK hydrogels were 27 
placed in a 24 well plate and 125 µl of the peptide solution was added to each well for 1 ½ hrs at RT 28 
on a rocker. For 5% and 1% DGEA either 0.656 mg or 0.131 mg, respectively, was added to 0.029 g 29 
NHS and 0.048 g EDCI in 1 ml dH2O and mixed until dissolved. The precast pεK hydrogels were placed 30 
in a 12 well plate and 250 µl of the peptide solution was added to each well for 1 ½ hrs at RT on a 31 
rocker. Peptide solution was then removed and 5 x 5 mins dH2O washes were performed prior to 32 
washing in 70% ethanol.   33 
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2.3. HCEC-12 cell culture  1 
Immortalised, transformed human corneal endothelial cells HCEC-12 cells (HCEC-12 (RRID:CVCL_2064) 2 
ACC 646, DSMZ) were grown in culture medium Hams F12 and Medium 199 (1:1) (Invitrogen, UK) with 3 
5% (v/v) fetal bovine serum (FBS) (Biosera, Labtech, UK). HCEC-12 cells were grown to 70-80% 4 
confluence and passaged using TrypLE Express (Invitrogen, UK) for 5 mins. Detached cells were 5 
collected in culture medium and centrifuged at 1000 rpm for 5 mins. Cell pellets were re-suspended 6 
in culture media and diluted to required cell density for use in experiments. HCEC-12 cells were used 7 
between passage 8-15 for experiments. 8 
2.4. Porcine corneal endothelial cell isolation and expansion  9 
Fresh porcine eyes were obtained from 6-month old pigs within 6 hours of slaughter from a local 10 
abattoir. The extra-ocular tissue was removed from eyes followed by a 2 min wash in PBS, (containing 11 
1% (v/v) penicillin/streptomycin and amphotericin B (P/S/AmpB) (Sigma, UK)). Eyes were immersed in 12 
povidone iodine (3% (v/v) Medisave, UK) diluted in PBS for 2 min and were washed twice in PBS to 13 
remove excess povidone iodine. Isolation of CECs was performed as previously reported with minor 14 
modifications.[37, 41] Briefly, corneas were excised from whole globes making an incision 3-4 mm 15 
from the posterior limbus and the anterior segment was obtained making a circumferential cut along 16 
the incision. The lens, iris and ciliary body and trabecular meshwork tissue were carefully removed. 17 
The corneas were rinsed 2-3 times in fresh PBS containing 1% (v/v) P/S/AmpB to remove any 18 
unwanted cells. Corneas were placed endothelium side up in a sterile Bijou cap in a 12 well plate and 19 
incubated with 300 µl TrypLE Express (Invitrogen, UK) for 15 min at 37°C, 5% CO2. Following 20 
incubation, CECs were isolated from both the central and peripheral regions as a single culture. CECs 21 
were released into the TrypLE Express solution by gentle scraping using a small inoculation loop to 22 
dislodge cells and pipetted into a well of a 6 well plate. A further 300 µl media was added to CE to 23 
ensure the capture of all endothelial cells. Isolated cells were re-suspended in culture medium (5 ml 24 
DMEM (Sigma, UK) with 10% FBS, 1% (v/v) P/S/AmpB)) and cultured in 6 well plates for 2 weeks and 25 
cell media was replaced every 2-3 days until confluence was achieved. Confluent cultures of porcine 26 
CECs showing characteristic regular hexagonal morphology were apparent after 2 weeks and were 27 
passaged into T25 flasks (passage 2) for further expansion and use for experimental studies at passage 28 
3. 29 
2.5. Cell seeding onto pεK hydrogel 30 
HCEC-12 cells and porcine CECs were dissociated from the culture dish using TrypLE Express for 10 min 31 
at 37°C, 5% CO2. Following enzyme dissociation, CECs were re-suspended in 5 ml of media and 32 
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centrifuged at 1000 rpm for 5 min. PεK hydrogels were transferred into 12 well tissue culture 1 
polystyrene (TCPS) plates and excess PBS was allowed to evaporate for approximately 15 min under 2 
sterile conditions. CECs were counted and seeded onto 8.5 mm diameter pεK hydrogels at a density 3 
of 1800 cells/mm2 (100 000 cells per pεK hydrogel) in a concentrated cell solution (50 µl) aliquoted to 4 
the centre of the pεK hydrogel and transferred to the incubator for approximately 2 hrs at 37°C 5% 5 
CO2 to allow cell adhesion. After 2 hrs a further 2 ml of media was gently added to the well and the 6 
pεK hydrogels were incubated for 24 hrs at 37°C 5% CO2. After 24 hrs in culture the pεK hydrogels plus 7 
attached cells were transferred into fresh 12 well TCPS plates with fresh pCEC culture media, thus 8 
excluding any pCECs that may have adhered to the bottom of the original 12 well TCPS plates. Cell 9 
medium was replaced every 2-3 days until confluence was achieved.   10 
2.6. Analysis of cell adherence to pεK hydrogel 11 
The number of cells adhered to the pεK hydrogel surface was measured as a longitudinal study at 24 12 
hrs, 4 days, 7 days, and 5 weeks, replacing the media every 3 days for long term cultures. Cells which 13 
remained rounded were not deemed adhered to the pεK hydrogel. To quantify the number of cells 14 
adhered to the pεK hydrogel, 3-5 randomised fields of view were imaged per pεK hydrogel, using 15 
phase contrast microscopy on live cells using a Nikon Eclipse Ti-E microscope (Nikon, UK). The same 16 
pεK hydrogel with cells was imaged at the specified time points until the experiment was terminated 17 
at the final time point. Cells were quantified using ImageJ 1.48v, images were processed to enhance 18 
brightness and contrast using the threshold tool to discriminate cell boundaries. The plugin Cell 19 
Counter tool on Image J was used to mark and count individual cells.   20 
2.7. Immunocytochemistry 21 
PεK hydrogel/cell constructs were washed briefly in PBS and fixed in 10% (v/v) neutral buffered 22 
formalin (Sigma, UK) for 10 min. HCEC-12 and pCECs were permeabilised with 0.1% (v/v) Triton X 100 23 
(Sigma, UK) in PBS) at RT for 5 min. Non-specific binding sites were blocked for 30 min at RT with 300 24 
µl blocking buffer (10% (v/v) Normal Goat Serum (Sigma, UK) in PBS). Samples were incubated with 25 
primary antibody zonula occludens 1 (ZO-1) (Invitrogen Rabbit polyclonal 40-2200) 250 g/ml, 1:40) 26 
and Na+/K+ATPase (Santa Cruz #sc-58628, Mouse monoclonal IgG1, 200 µg/ml, 1:20) overnight at 4C 27 
then washed 3 times for 5 mins with PBS (0.05% (v/v) Tween-20 (Sigma, UK)). PεK hydrogels were 28 
incubated with secondary antibody (Alexa Fluor 488 Goat anti-Rabbit and Alexa Fluor 488 Goat anti-29 
Mouse (Invitrogen, UK)) and isotype control for 1 hr in the dark at RT, followed by 3 PBS washes for 5 30 
mins each. PεK hydrogels were stained with Hoechst 33442 (Thermo Fisher, UK) for 15 min, washed 31 
in PBS and imaged using Nikon Ti microscope, using the Z stack option to create a compiled image for 32 
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brightfield images. A Zeiss confocal LSM800 and Nikon Eclipse Ti-E microscope was used for 1 
immunofluorescence images using z stacks to compile a focused image.  2 
2.8. Statistical analyses  3 
Data was presented as the mean and standard deviation (SD) of at least three independent 4 
experiments (n=3), with each independent experiment being performed on a minimum of 3 pεK 5 
hydrogels for each condition. One-way analyses of variance (ANOVA) and post-hoc Tukey’s HSD test 6 
were performed to evaluate statistical significances between groups of samples. All statistical analyses 7 
were performed using Minitab 17.0. Statistical significance is shown using the p-value of p<0.05 (*).  8 
3. Results 9 
3.1 PεK hydrogels are transparent and easy to manipulate   10 
Thin, transparent pεK hydrogel films (Figure 1A) were fabricated with an open porous structure 11 
demonstrated by AFM (Figure 1B), an average of 118 µm (SD 16 µm) thickness was observed for gels 12 
synthesised for cell culture (Table 1). The pεK hydrogels had an average stiffness and ultimate tensile 13 
strength of 0.11 MPa and 0.04 MPa, respectively (Table 1). As expected, contact angle analysis 14 
revealed the pεK hydrogel was hydrophilic with an average contact angle of 18.1° (SD 1.26) along with 15 
a high water content of 91.25% (SD 1.65) (Table 1). The pεK hydrogels had excellent transparent 16 
properties across all wavelengths of the visible spectrum, for example a 99.08% (SD 0.57) light 17 
transmission at 560 nm wavelength was observed (Table 1) (560 nm was chosen as a representative 18 
wavelength as values did not differ across the various wavelengths). This was not significantly different 19 
to the contact lens positive control, 100.4% (SD 1.28) (p>0.05). The mechanical properties of the pεK 20 
hydrogels meant that they were robust enough to be manipulated with forceps and handled as they 21 
would be in a surgical procedure (Figure 1C). 22 
3.2 HCEC-12 cell line, but not pCECs, adhered and remained attached on PƐK hydrogels after 7 days  23 
The HCEC-12 cells adhered to the pεK hydrogel at 24 hrs post seeding with an average cell density of 24 
281.50 cells/mm2 (SD 51.81), comparable to TCPS 288 cells/mm2 (SD 17.78) (no significant difference 25 
(p>0.05)) (Figure 2A,B). By 7 days HCEC-12 cells covered the pεK hydrogel surface to form a cell 26 
monolayer with an average cell density of 422.9 cells/mm2 (SD 87.88) (Figure 2C,D), which was 27 
comparable to TCPS 457.13 cells/mm2 (SD 78.32) (p>0.05) (Figure 2E). The number of HCEC-12 cells 28 
covering the pεK hydrogel surface at 7 days was significantly higher than at 24 hrs post seeding (Figure 29 
2E) (p<0.05). 30 
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Primary pCEC adherence on the pεK hydrogel was lower when compared to HCEC-12 cells or pCECs 1 
on TCPS at 24 hrs with an average cell density on the pεK hydrogel of 43.86 cells/mm2 (SD 13.23) 2 
(Figure 2F,G and J), compared to TCPS 1495.64 cells/mm2 (SD 403.12), significantly different (p<0.05). 3 
At 7 days pCECs covered the surface of the pεK hydrogel to achieve an average cell density of 81.82 4 
cells/mm2 (SD 38.49) (Figure 2H,I and J), significantly different compared to TCPS 1893.27 cells/mm2 5 
(SD 170.41) (p<0.05). Although there were regions of high pCEC density on the pεK hydrogels, it was 6 
evident that pCECs had detached from regions of the pεK hydrogel surface as sheets at 7 days (Figure 7 
2I).  8 
3.3 Pre-adsorbing collagen I, collagen IV and fibronectin onto pεK hydrogels improved the adhesion 9 
and morphology of pCECs 10 
There was increase in the number of pCECs adhered to the pεK hydrogel surface which were pre 11 
adsorbed with either collagen I, collagen IV or fibronectin at 24 hrs, compared to the untreated pεK 12 
hydrogels (Figure 3A-H). An average cell density of 1958 cells/mm2 (SD 896.31) for collagen I, 1471.6 13 
cells/mm2 (SD 774.43) collagen IV and 1112.19 cells/mm2 (SD 744.55) for fibronectin was achieved 14 
compared to 128.43 cells/mm2 (SD 129.07) for untreated pεK hydrogels (p<0.05) (Figure 3I). There 15 
was no significant difference between the numbers of pCECs on the pεK hydrogel surface whether it 16 
had been pre-adsorbed with collagen I, IV or fibronectin (Figure 3I) (p>0.05). There was variation in 17 
the cell number across the pεK hydrogel surface, thus accounting for the large standard deviations at 18 
the 24 hr time point. The addition of FNC coat, chondroitin sulfate, laminin or a mix of both chondroitin 19 
sulfate and laminin did not significantly improve the cell density on the pεK hydrogel (p>0.05), 20 
compared to the untreated pεK hydrogel (Figure 3A, E-I). 21 
Representative images of pCECs on the pεK hydrogels with pre-adsorbed collagen I, collagen IV and 22 
fibronectin at 2 days, 4 days and 7 days, showed that pCECs formed confluent monolayers at 7 days 23 
across the pεK hydrogel surfaces (Figure 4A-L). The pCEC monolayers remained attached to the pεK 24 
hydrogel surface at 7 days on pεK hydrogels pre-adsorbed with collagen I, collagen IV and fibronectin, 25 
in comparison to the untreated pεK hydrogel, which displayed regions of pCECs detachment (Figure 26 
4C,F,I,L). Representative images of pCECs show compact monolayers exhibiting the characteristic 27 
hexagonal appearance typical of primary pCECs on these surfaces, in comparison to the untreated pεK 28 
hydrogel. 29 
3.4 RGD but not DGEA functionalisation of pεK hydrogels increased adhesion of pCECs in long term 30 
cultures  31 
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It was demonstrated by phase contrast microscopy that there were less pCEC coverage on the non 1 
functionalised pεK hydrogels (Figure 5A-C), DGEA 1% (Figure 5D-F), DGEA 5% (Figure 5G-I) at 24 hrs, 4 2 
days and 7 days, when compared to the RGD (Figure 5J-L) pεK hydrogels. Cell adhesion to the DGEA 3 
functionalised pεK hydrogels was low and comparable to the non-functionalised pεK hydrogel.  4 
The number of pCECs adhered to the RGD functionalised pεK hydrogel surface was monitored by 5 
phase contrast imaging of live pCECs on pεK hydrogels at 24 hrs, 4 days and 7 days, compared to non 6 
functionalised pεK hydrogels and TCPS (Figure 6A-I). The average number of cells covering the RGD  7 
functionalised pεK hydrogels surface at 24 hrs was 1418 cells/mm2 (SD 65.07) and was comparable to 8 
TCPS with an average of 1495 cells/mm2 (SD 403.12) (Figure 6J). No significant difference was observed 9 
between the RGD functionalised pεK hydrogel and TCPS (p>0.05), at any time point (Figure 6J). The 10 
number of pCECs covering the non functionalised pεK hydrogels surface at 24 hrs was 187 cells/mm2 11 
(SD 104.99).  12 
By day 4 and 7 the number of pCECs on the RGD functionalised pεK hydrogel remained comparable to 13 
TCPS (Figure 6E,F,H,I). On day 4, 1729.12 cells/mm2 (SD 279.95) covered the RGD functionalised pεK 14 
hydrogel surface, comparable to TCPS 1728.29 cells/mm2 (SD 685.54) (p>0.05) (Figure 6J). On day 7, 15 
2219.19 cells/mm2 (SD 171.09) covered the RGD functionalised pεK hydrogel surface, comparable to 16 
TCPS 1893.27 cells/mm2 (SD 170.41) (p>0.05) (Figure 6J). The pCECs on the non-functionalised pεK 17 
hydrogel had detached from the surface by 7 days (Figure 6C).   18 
pCECs on RGD functionalised pεK hydrogels were maintained in culture for up to 5 weeks post seeding 19 
and a monolayer of cells remained adhered to the pεK hydrogel surface without any regions of cell 20 
detachment, compared to the non-functionalised pεK hydrogel where no cells were present on the 21 
surface (Figure 7A and B). The cell density on these pεK hydrogels at 5 weeks post culture (longest 22 
time point monitored) was an average of 2548 cells/mm2 (SD 159.48). pCEC monolayers displayed 23 
characteristic CEC hexagonal morphology and immunofluorescence staining for ZO-1 was localised at 24 
the cell-cell junctions, indicating tight junction formation (Figure 7C-E) To validate the presence of a 25 
functional monolayer, immunocytochemistry for Na+/K+ATPase showed positive membrane staining 26 
of CECs, suggesting the presence of a functional Na+/K+ATPase pump (Figure 7F-H). 27 
4. Discussion 28 
Corneal endothelial injury or dysfunction is currently treated with a corneal transplant with one donor 29 
endothelium being used to treat one patient. The opportunity to expand CECs on tissue engineered 30 
substrates offers an important alternative treatment to enable multiple recipients to be treated from 31 
a single donor. We have demonstrated in this study that we were able to fabricate thin, transparent 32 
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pεK hydrogels, which can be fine-tuned to control for cell adhesion, enabling the in vitro expansion 1 
and support of primary CECs whilst maintaining their phenotypic markers. It was determined that pre-2 
adsorption of proteins collagen I, collagen IV and fibronectin increased pCEC adhesion on pεK 3 
hydrogels. Functionalisation of the pεK hydrogel surface with the RGD peptide increased cell adhesion 4 
and expansion of pCECs and at 5 weeks these cells had formed a monolayer with expression of ZO-1 5 
and Na+/K+ATPase, indicating the formation of tight junctions and presence of functional pumps, 6 
respectively.    7 
PεK hydrogels used in this study are synthesised from pεK and dicarboxylic acids using carbodiimide 8 
chemistry and can be easily and rapidly manufactured from relatively inexpensive reagents, however, 9 
we appreciate that there is some variability in our current method of the pεK hydrogel manufacturing 10 
process, and parameters such as temperature and humidity would need to be more tightly controlled 11 
to upscale the process to a more reproducible method for commercial use. A significant advantage of 12 
pεK hydrogels is that we can tailor the mechanical properties of the pεK hydrogel to fit specific 13 
requirements. In this study, a pεK hydrogel with polymer density 0.066 g/ml cross-linked to 60% with 14 
octanedioic-acid was initially used as previous research had demonstrated that this pεK hydrogel was 15 
robust enough to handle easily.[38, 39] The pεK hydrogels had a modulus of 0.11 MPa and ultimate 16 
tensile strength of 0.04 MPa. These figures differ from the modulus of human DM, the substrate for 17 
the native endothelium, which is 0.05 MPa (range 0.02-0.08) and the ultimate tensile strength, which 18 
is 0.3 MPa.[42] The important point to note, however, is that the hydrogel can be easily manipulated, 19 
as they would be during DSAEK surgery, without significant loss of cells or substrate integrity. Other 20 
materials that have been trialled as a substrate for an engineered endothelial layer such as pre-wet 21 
silk fibroin have demonstrated a Young’s modulus of 0.022 MPa and ultimate tensile strength of 2.1 22 
MPa [43], however these materials have been too fragile to handle. We did not intend to produce a 23 
material with mechanical properties approximating the DM, as one of the problems with DMEK 24 
surgery is the high level of surgical skill required to handle the DMEK scroll.[44] It is a delicate tissue 25 
that can be easily damaged during the stripping and unfolding procedures so we aimed to produce a 26 
hydrogel that had improved robustness and was easier to unfold; effectively an intermediate between 27 
a DMEK and DSAEK graft combining the advantages of DSAEK tissue in terms of ease of handling and 28 
unfolding with the superior visual outcomes of the thinner DMEK tissue. In a recent review [45] the 29 
authors discuss the relative mechanical properties of natural materials for corneal tissue engineering 30 
and demonstrate that the elastic modulus varies considerably depending on the orientation and depth 31 
of the tissue sample (cornea and amniotic membrane) and the method of testing (uniaxial tension, 32 
compression or microindentation) but are generally in the range 0.3 to 3.0 MPa. In contrast to the 33 
natural tissues, the mechanical properties of purified materials such as collagen 1 and silk fibroin can 34 
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be tailored by optimising the cross-linking. A similar approach can be taken with the pεK used in this 1 
study leading to greater control over the design of the substrate for both cell interactions and surgical 2 
handling. In comparison to collagen 1 and silk fibroin the pεK is inexpensive and readily available as a 3 
pharmaceutical grade material. 4 
Substrates for the replacement of CE must be porous, thin and transparent, to allow the passage of 5 
fluid and nutrients from the aqueous humour into the stroma, as well as allowing the passage of light. 6 
We have demonstrated in this current study that our pεK hydrogel has an open porous network, 7 
observed via AFM, and that it is possible to cast thin pεK hydrogels (~100µm). The pεK hydrogel was 8 
hydrophilic (contact angle 18.1°), most likely due to the presence of amines on the surface and the 9 
high water content within the pεK hydrogel (water content of 91.25%), had excellent transparency 10 
allowing the passage of light across all wavelengths of the visible spectrum (99.08% light transmission), 11 
and excellent cytocompatibility for other ocular applications. One reported example is the potential 12 
use of these pεK hydrogels as antimicrobial contact lenses, demonstrating that the pεK hydrogels 13 
showed good cytocompatibility with corneal epithelial cells.[38]  14 
The pεK hydrogel provides a platform that can be modified and tailored to specific cell requirements 15 
to control for cell attachment. As the crosslinking density of the pεK hydrogel increases, the number 16 
of free amine functional groups decreases and the stiffness of the pεK hydrogels increases. Both these 17 
properties can influence the interaction of cells with surfaces, thus altering cell activity and 18 
attachment. Our synthesised pεK hydrogel theoretically has 40% of the amine groups unbound and 19 
free. The amine surface of the pεK hydrogel not only promotes cell interactions but provides useful 20 
binding sites for biomolecules allowing specific functionalisation of the surface, either by pre-21 
adsorption of ECM proteins or covalent binding of additional peptides. The non-functionalised pεK 22 
hydrogel seeded with the HCEC-12 cell line showed promising results, forming a confluent monolayer 23 
of cells with characteristic CEC hexagonal morphology and the numbers of cells present were 24 
comparable to cells on TCPS. However, primary pCEC attachment was significantly lower and although 25 
confluent monolayers were achieved, by 7 days, detachment of cell monolayers from the pεK hydrogel 26 
was observed. The differences between cell line and primary cells, with the primary pCECs detaching 27 
away from the pεK hydrogel surface as sheets, suggests the primary cells had a stronger attachment 28 
to one another rather than the material surface perhaps due to less deposition of a basement 29 
membrane (BM), although this would require confirmation by characterising the deposited ECM. The 30 
HCEC-12 cell line may have a lower requirement for cell adhesion or secrete more BM proteins in a 31 
short period of time compared to the pCECs to enable maintenance of a cell monolayer. We and others 32 
have reported that primary human corneal epithelial cells require long term culture (>3 weeks) to 33 
secrete substantial amounts of basement membrane proteins [46] and that the presence of 34 
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neighbouring cells (stromal[46] or corneal endothelial cells[47]) in organotypic 3D cultures leads to 1 
the synthesis of a nearly continuous basement membrane. One mechanism that could explain this 2 
effect is that the neighbouring cells may produce a cytokine or matrix component that stimulates the 3 
epithelial cells to differentiate and assemble a basement membrane. It is likely that the stromal or 4 
epithelial cells also signal to the endothelial cells in a feedback loop. In the present study, primary 5 
endothelial cells were cultured in isolation so are not exposed to any such signalling, consequently, 6 
production of their own matrix may be substantially delayed. In order to ameliorate this, addition of 7 
exogenous ECM proteins on culture surfaces or biomaterials is a viable option. Modification of the PeK 8 
hydrogel with peptides/proteins clearly elicits different cellular responses, however, in this study we 9 
have not quantified the amount of bound peptide/proteins as it is challenging in this setting. The 10 
peptide structure of the PeK hydrogel masks the spectroscopic peaks of the attached peptides if using 11 
Fourier transform infrared spectroscopy (FTIR) and reagent absorption by the hydrogel creates 12 
considerable variability in background readings in ELISA based assays. 13 
The DM is composed predominantly of collagen IV, collagen VIII, laminin and fibronectin.[48] Others 14 
have shown that mimicking the structure of DM, for example, with a dense layer of collagen IV and 15 
laminin (bovine cells) or collagen IV alone (human cells) encouraged endothelial cells to form high 16 
density monolayers that adhered to an underlying collagen I substrate.[49, 50] ECM proteins and 17 
substrates that mimic mechanical and biological properties of DM have been shown to be more 18 
favourable, increasing cell attachment and maintaining characteristic endothelial cell morphology.[33, 19 
51, 52] In this present study we showed that electrostatic binding of ECM proteins (collagen I, collagen 20 
IV and fibronectin) to the surface of our pεK hydrogels improved attachment, maintenance of a cell 21 
monolayer and sustained the cell sheet adhesion at 7 days.  Another study demonstrated that human 22 
CECs cultured on collagen I, collagen IV, fibronectin and commercial FNC coat attached well and spread 23 
but were only weakly attached to laminin and TCPS control plates.[53] This agrees with the findings 24 
of our study that the laminin did not increase adhesion of the primary porcine cells. Others have also 25 
modified the surface of their materials to increase cell attachment. Silk fibroin lacks ECM proteins and 26 
studies have shown that modification of the substrate via the incorporation of pre-adsorbed ECM 27 
proteins (collagen IV) onto the surface, promoted attachment and proliferation of human CECs.[29] 28 
Palchesko et al. also demonstrated that bovine CECs could be cultured on a poly(dimethylsiloxane) 29 
surface and the adhesion and morphology of CECs was improved with collagen IV proteins.[40]  30 
Although coating with natural ECM molecules appears to be beneficial to CEC adhesion and growth, 31 
they do have some disadvantages. An interesting solution to this problem was described by Rizwan et 32 
al. in 2017 using gelatin methacrylate (GelMA) as the base for a tissue engineered graft.[54] Instead 33 
of coating the surface of the hydrogel with ECM proteins themselves they nano-patterned the surface 34 
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to mimic the nanoscale topographical cues contained on in vivo extracellular matrix. They showed that 1 
the topographical cues were able to improve the cell functions and phenotype of a CEC monolayer. It 2 
is preferable to use chemically and physically defined ECM mimics that can be reliably reproduced so 3 
this approach could be useful if direct functionalisation of the surface with synthetic peptides is not 4 
possible. We have successfully shown that we are able to functionalise the pεK hydrogel through 5 
covalent binding of synthetic ECM adhesive peptides, DGEA and RGD. Integrins form an important and 6 
widespread group of adhesion receptors as they interact with proteins of the extracellular matrix or 7 
with the receptors expressed on cells as shown in the binding of the leukocyte integrins to the 8 
intercellular adhesion molecules (ICAMs).[55] DGEA (Asp-Gly-Glu-Ala), corresponding to residues 425-9 
438 of the Type 1 collagen sequence, has been identified as a recognition motif used by the type I 10 
collagen to bind to α2β1 integrin.[56] The RGD peptide (Arg-Gly-Asp) is the most widely studied 11 
adhesive peptide and is the principal integrin binding domain present within ECM proteins such as 12 
fibronectin, vitronectin, fibrinogen and others. PεK hydrogels functionalised with RGD did facilitate 13 
pCEC adhesion, however, pCECs were unable to adhere to the surface of pεK hydrogels functionalised 14 
with DGEA. DGEA therefore did not appear to serve as an adhesion ligand for pCECs in this context. 15 
These results are consistent with a previously reported study describing rat calvarial osteoblasts and 16 
MC3TT3-E1 osteoblasts demonstrating limited adhesion on hydrogel surfaces presenting the DGEA 17 
peptide, which was described as ‘weakly adhesive’.[57, 58]. The glycine-phenylalanine-18 
hydroxyproline-glycine-glutamate-arginine (GFOGER) peptide could be an alternative collagen I 19 
peptide to trial in the future. It known to provide a significant basal level of adhesivity along with 20 
RGD[59] and the integrin α2β1 recognizes the GFOGER motif in residues 502–507 of the α1 chain of 21 
type I collagen. Not only has the α2β1 integrin been identified on corneal endothelial cells [60] but 22 
the expression of β1 integrin has also been shown to be upregulated in cultured corneal endothelial 23 
cells when compared with native tissue, so this fact can be exploited with designing peptide 24 
functionalisation for tissue engineered endothelial grafts.[61] 25 
The biomimetic RGD domain is able to promote cell adherence to the pεK hydrogel surface and 26 
improve the cell/material interactions for many different applications.[62, 63] The advantage of using 27 
an RGD peptide instead of a natural protein is a reduction in immune reactivity or pathogen transfer, 28 
synthesis is easy and inexpensive and it can be performed in a controlled and defined manner.[64] For 29 
example, the coupling of the RGD peptide to silk was beneficial in enhancing the cell attachment and 30 
proliferation of corneal stromal cells in tissue engineering of the corneal stromal lamellae, which when 31 
implanted into an animal model, maintained their functionality.[65, 66]  32 
This study has demonstrated that pεK hydrogels offer a compatible substrate to support the expansion 33 
and growth of a human corneal endothelial cell line and primary pCECs in vitro. We found that the 34 
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addition of pre-adsorbed collagen I, collagen IV and fibronectin increased the cell adhesion onto the 1 
pεK hydrogel and the cells remained attached at 7 days. The free amine sites on the pεK hydrogel 2 
enabled the functionalisation of the pεK hydrogel surfaces with RGD and DGEA cell binding peptides. 3 
The results demonstrated that bound RGD increased cell adhesion compared to non-functionalised 4 
pεK hydrogels and maintained cell attachment up to 5 weeks in culture. Long term cultures exhibited 5 
a characteristic CEC phenotype which showed the formation of tight junctions at the cell boundary 6 
and expression of Na+/K+ATPase demonstrating the functionality of the cell monolayer.  7 
5. Conclusions 8 
Tissue engineered corneal endothelial grafts are being developed by a number of research groups in 9 
order to alleviate pressure on the demand for transplant tissue due to a worldwide donor cornea 10 
shortage. Our pεK hydrogel has great potential as a clinically viable option as the peptide is readily 11 
available in a purified state, its mechanical properties are customisable by design of the cross-linking 12 
density and it can be surface functionalised via free amine groups for any particular application. We 13 
have tailored the mechanical properties to enable easy handling of the graft by surgeons and 14 
functionalised the surface to improve corneal endothelial cell attachment. Successful development 15 
along the translational pipeline could see this technology being delivered to patients to treat 16 
endothelial dysfunction.   17 
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Figure captions 26 
Table 1. Physical properties of a pεK hydrogel cross-linked to 60% with octanedioic-acid to a polymer 27 
density of 0.066 g/ml n=3. 28 
Figure 1. (A) Representative photograph of a pεK hydrogel cross-linked to 60% with octanedioic-acid 29 
to a polymer density of 0.066 g/ml demonstrating a thin transparent hydrogel, (B) Atomic force 30 
micrograph detailing the microporous structure of the same pεK hydrogel. (C) Image to show how 31 
the hydrogels can be manipulated easily using forceps.  32 
17 
 
Figure 2. HCEC-12 and pCEC expansion on a pεK hydrogel cross-linked to 60% with octanedioic-acid 1 
to a polymer density of 0.066 g/ml. HCEC-12 cells and pCECs were seeded onto pεK hydrogels at a 2 
density of 1x105 cells per pεK hydrogel (1800 cells/mm2). Representative phase contrast images of 3 
HCEC-12 cells expanded 24 hrs on (A) TCPS and (B) pεK hydrogel or at 7 days and on (C) TCPS (D) pεK 4 
hydrogel. (E) Quantification of cell density (cells/mm2) at 24 hrs and 7 days post seeding of HCEC-12 5 
cells on hydrogels. Representative images of pCECs seeded at 24 hrs on (F) TCPS and (G) pεK 6 
hydrogel or at 7 days on (H) TCPS and (I) pεK hydrogel. (J) Quantification of cell density (cells/mm2) 7 
at 24 hrs and 7 days post seeding of pCECs on hydrogels. Scale bar 100μm, n= 4 for HCEC-12 pεK 8 
hydrogels, n=3 for pCECs. Error bars show SD. Symbol * represents significant difference (p<0.05) 9 
using one way ANOVA and post-hoc Tukey’s HSD analysis across groups. 10 
 11 
Figure 3. Representative phase contrast images of adhesion of pCECs on a pεK hydrogel cross-linked 12 
to 60% with octanedioic-acid to a polymer density of 0.066 g/ml pre adsorbed with ECM proteins. 13 
PεK hydrogels were uncoated (A) or electrostatically bound for 1 hr with proteins (B) collagen I 100 14 
μg/ml, (C) collagen IV 50 μg/ml, (D) fibronectin 50 μg/ml, (E) chondroitin sulfate 20 mg/ml, (F) 15 
Laminin and chondroitin sulfate (G) laminin 50 μg/ml, and (H) FNC coat. pCECs were seeded onto 16 
hydrogels at a cell density of 1800 cells/mm2. PεK hydrogels were imaged 24 hrs post seeding. Scale 17 
bar 100 μm, n=3. (I) Quantification of cell density (cells/mm2). Symbol * denotes significantly 18 
different p<0.05 compared to pεK hydrogel only using ANOVA and post-hoc Tukey’s HSD analysis, 19 
Error bars show SD. 20 
Figure 4. Adhesion and expansion of pCECs on a pεK hydrogel cross-linked to 60% with octanedioic-21 
acid to a polymer density of 0.066 g/ml pre-adsorbed with ECM proteins. PεK hydrogels (A-C) were 22 
electrostatically bound with proteins for 1 hr with (D-F) collagen I 100 μg/ml, (G-I) collagen IV 50 23 
μg/ml and (J-L) fibronectin 50 μg/ml. pCECs were seeded onto pεK hydrogels at a cell density of 1800 24 
cells/mm2. PεK hydrogels were imaged 2 days, 4 days and 7 days post seeding. Scale bar 100 μm. 25 
Figure 5. Primary pCECs seeded on pεK hydrogels cross-linked to 60% with octanedioic-acid to a 26 
polymer density of 0.066 g/ml and non-functionalised or functionalised with DGEA and RGD. 27 
Representative phase contrast images of pCECs expanded for 24 hrs, 4 and 7 days respectively on (A-28 
C) non-functionalised pεK hydrogels, (D-F) DGEA 1% functionalised pεK hydrogels, (G-I) DGEA 5% 29 
functionalised pεK hydrogels and (J-L) RGD functionalised pεK hydrogels. Scale bar 100 μm. 30 
Figure 6. Primary pCECs seeded onto a pεK hydrogel cross-linked to 60% with octanedioic-acid to a 31 
polymer density of 0.066 g/ml with/without RGD functionalisation. PεK hydrogels were imaged at 24 32 
hrs, 4 days and 7 days.  Representative images of cells expanded on (A-C) non-functionalised or (D-F) 33 
RGD functionalised pεK hydrogels or (G-I) TCPS. (J) Quantification of cell density (mm2) on pεK 34 
hydrogels at specified time points. pCECs were seeded onto pεK hydrogels at a cell density of 1800 35 
cells/mm2. Scale bar 100 µm, n= 3. Error bars show SD. Symbol * represents significant difference 36 
(p<0.05) using one way ANOVA and post-hoc Tukey’s HSD analysis across groups. 37 
 38 
Figure 7. Long term culture of pCECs expanded on hydrogels. (A) non-functionalised hydrogel (B) 39 
RGD functionalised hydrogel 5 weeks post seeding of pCECs. Scale bars 100 µm. (C) ICC of ZO-1 40 
(green) and Hoechst 33342 (blue). Monocoloured images (D) ZO1 and (E) Hoechst 33342. (F) 41 
Na+/K+ATPase (green) and Hoechst 33342 (blue) expression. Monocolour images (G) Na+/K+ATPase 42 
and (H) Hoechst 33342. Scale bars 20 µm. 43 
 44 
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